Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes

This publication has 28 references indexed in Scilit:

• Bradykinin and the therapeutic actions of angiotensin-converting enzyme inhibitors
  The American Journal of Cardiology, 1998
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
  Published by Elsevier ,1997
• Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells.
  Journal of Clinical Investigation, 1996
• Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
  Journal of the American College of Cardiology, 1996
• Effect of Chronic Angiotensin-Converting Enzyme Inhibition on Endothelial Function in Patients with Chronic Heart Failure
  The American Journal of Cardiology, 1995
• Endothelium-Derived Relaxing Factors and Converting Enzyme Inhibition
  The American Journal of Cardiology, 1995
• A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of Various Doses of Losartan Potassium Compared With Enalapril Maleate in Patients With Essential Hypertension
  Hypertension, 1995
• Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure
  Journal of the American College of Cardiology, 1994
• Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism
  Cardiovascular Research, 1994
• Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients.
  Hypertension, 1992